Back to Trades
JOHNSON & JOHNSON
JNJCIK: 0000200406
Follow JNJ
Track JOHNSON & JOHNSON insider trades on your dashboard. Email alerts with a subscription.
JOHNSON & JOHNSON (JNJ) has recorded 50 insider filings from 22 unique insiders, totaling $311.1M in trading activity (net selling). Insiders have sold $86.1M while purchasing $257.7K. Insider sales can reflect personal financial planning rather than a bearish view — always consider the full context. The most active insider by volume is Duato Joaquin. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.
Total Volume
$311.1M
Purchases
$257.7K
Sales
$86.1M
Unique Insiders
22
Recent Insider Trades
50 loaded
| Jun 12 | JNJ JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Sell | $2.4M |
| Jun 11 | JNJ JOHNSON & JOHNSON | HEWSON MARILLYN A | Director | Other | $0 |
| Jun 11 | JNJ JOHNSON & JOHNSON | Woods Eugene A. | Director | Other | $0 |
| Jun 11 | JNJ JOHNSON & JOHNSON | Pinto Daniel E | Director | Other | $0 |
| May 4 | JNJ JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | Other | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | MORIKIS JOHN G | Director | Other | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | WEINBERGER MARK A | Director | Other | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | HEWSON MARILLYN A | Director | Other | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | West Nadja | Director | Other | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | Joly Hubert | Director | Other | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | Woods Eugene A. | Director | Other | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | Beckerle Mary C | Director | Other | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | Pinto Daniel E | Director | Other | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | Johnson Paula A | Director | Other | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | Doudna Jennifer A | Director | Other | $0 |
| Apr 27 | JNJ JOHNSON & JOHNSON | McClellan Mark B. | Director | Other | $0 |
| Mar 12 | JNJ JOHNSON & JOHNSON | Woods Eugene A. | Director | Other | $0 |
| Mar 12 | JNJ JOHNSON & JOHNSON | Pinto Daniel E | Director | Other | $0 |
| Feb 23 | JNJ JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | Sell | $324.8K |
| Feb 18 | JNJ JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | $13.1M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board, Director | Other | $0 |
| Feb 18 | JNJ JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | Sell | $1.5M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Other | $0 |
| Feb 18 | JNJ JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | Sell | $15.1M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Mulholland Kristen | EVP, Chief HR Officer | Other | $0 |
| Feb 18 | JNJ JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | Sell | $5.5M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | Sell | $21.8M |
| Feb 18 | JNJ JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Other | $0 |
| Feb 18 | JNJ JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | Other | $0 |
| Feb 18 | JNJ JOHNSON & JOHNSON | Forminard Elizabeth | EVP, Chief Legal Officer | Other | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board, Director | Other | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | Other | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Mulholland Kristen | EVP, Chief HR Officer | Other | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | Other | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Forminard Elizabeth | EVP, Chief Legal Officer | Other | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | Other | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | Other | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Other | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | Other | $0 |
| Feb 11 | JNJ JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Other | $0 |
| Feb 9 | JNJ JOHNSON & JOHNSON | Mulholland Kristen | EVP, Chief HR Officer | Other | $0 |
| Feb 9 | JNJ JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Other | $0 |
| Feb 10 | JNJ JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | Other | $0 |
| Feb 6 | JNJ JOHNSON & JOHNSON | Forminard Elizabeth | EVP, Chief Legal Officer | Other | $0 |
| Jan 28 | JNJ JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board, Director | Sell | $22.1M |
| Dec 11 | JNJ JOHNSON & JOHNSON | HEWSON MARILLYN A | Director | Other | $0 |
| Dec 11 | JNJ JOHNSON & JOHNSON | Woods Eugene A. | Director | Other | $0 |
| Dec 11 | JNJ JOHNSON & JOHNSON | Pinto Daniel E | Director | Other | $0 |
| Dec 1 | JNJ JOHNSON & JOHNSON | MORIKIS JOHN G | Director | Buy | $257.7K |
| Oct 20 | JNJ JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | $4.2M |
50 filings+